Mentholatum Australasia welcomes Pain Away to its portfolio

– Brings together Deep Heat, ICE and Pain Away under one roof –

Melbourne, Australia, 14 September 2026 – Mentholatum Australasia today announced the completion of its acquisition of the Australian pain relief brand Pain Away, bringing together three of the country's most recognised pain relief brands in Deep Heat, ICE and Pain Away.

The acquisition marks an important milestone for Mentholatum Australasia and further strengthens its position in the pain management and care category. Together, Deep Heat, ICE and Pain Away offer a broad range of pain relief solutions spanning heat therapy, cold therapy and anti-inflammatory formulations, helping consumers stay active and manage everyday aches and pains with confidence.

Established in Australia in 1999, Pain Away has built a loyal following through its range of topical pain relief products, featuring active ingredients traditionally used in Western medicine, such as Arnica. Deep Heat has supported Australians with muscle and joint pain for more than 70 years, while ICE has become a trusted choice for cooling pain relief and recovery support.

Simon Tregeagle, Country General Manager, Mentholatum Australasia, said: "Pain Away is a highly regarded brand that has earned the trust of consumers for more than two decades, and we're pleased to welcome it into our growing portfolio of health, wellness and skincare brands.

"Our vision is to Make People’s Lives Healthier and Happier and bringing Pain Away into Mentholatum alongside Deep Heat and ICE gives us a strong range of trusted pain relief brands. Each has built its own loyal following over many years, and together they allow us to support consumers with a broader range of solutions to help them keep moving and stay active.

"Pain relief is no longer a one-size-fits-all category. Consumers are increasingly looking for solutions that align with their individual preferences, whether that's heat therapy, cold therapy or anti-inflammatory pain relief. We are now better positioned to meet those diverse needs.

"As a company with a long history in Australia and New Zealand, we're committed to investing in all three brands through innovation, marketing, manufacturing excellence and strong customer partnerships. We see significant opportunities to grow the category and continue supporting consumers with trusted self-care solutions," said Mr Tregeagle.

The acquisition aligns with parent company Rohto Pharmaceutical's vision of supporting wellbeing and longevity through preventative health and self-care solutions.

Mentholatum Australasia will continue to market and develop the Pain Away, Deep Heat and ICE brands, leveraging its local expertise in sales, marketing, manufacturing, regulatory affairs and consumer healthcare innovation.

About Mentholatum Australasia

Mentholatum Australasia Pty Ltd is part of The Mentholatum Company, a global health and wellness business owned by Rohto Pharmaceutical Co. Ltd. The Rohto / Mentholatum Group operates across international markets with a portfolio of trusted consumer healthcare, personal care, skincare and eye care brands. In Australasia, Mentholatum’s success combines local marketing, sales, manufacturing, regulatory and strategic capabilities to support ongoing growth and innovation. Pain Away is a strong strategic fit with Mentholatum’s product range which supports our purpose of making people’s lives healthier and happier together with our values of trust, integrity, collaboration and continuous improvement. The acquisition provides an opportunity to expand a high-quality Australian health and wellness brand within a values-led global consumer healthcare business.